Sera Prognostics Inc. Announces Preliminary Efficacy Met in Pivotal Prime Study Interim Look - Enrollment to Stop Due to Success
Sera Prognostics Inc. announced that the Data Safety Monitoring Board overseeing its pivotal Prematurity Risk Assessment Combined with Clinical Interventions for Improved Neonatal OutcoMEs study...
United States Sera Prognostics Inc Sera Prognostics Data Safety Monitoring Board Prematurity Risk Assessment Combined Clinical Interventions
Source: marketscreener.com